Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
408 hedge funds and large institutions have $17.2B invested in Immunomedics Inc in 2020 Q3 according to their latest regulatory filings, with 160 funds opening new positions, 87 increasing their positions, 134 reducing their positions, and 64 closing their positions.
325% more funds holding in top 10
Funds holding in top 10: 16 → 68 (+52)
150% more first-time investments, than exits
New positions opened: 160 | Existing positions closed: 64
134% more capital invested
Capital invested by funds: $7.38B → $17.2B (+$9.87B)
36% more call options, than puts
Call options by funds: $398M | Put options by funds: $293M
30% more funds holding
Funds holding: 313 → 408 (+95)
35% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 134
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HI
HBK Investments
Dallas,
Texas
|
+$329M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$296M |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$198M |
| 4 |
DKCM
Davidson Kempner Capital Management
New York
|
+$154M |
| 5 |
TAL
TIG Advisors LLC
New York
|
+$96.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$486M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$280M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$205M |
| 4 |
Alkeon Capital Management
New York
|
-$164M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$163M |
IMMU Hedge Fund Activity: Q3 2020 in Review
408 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q3 2020, worth a combined $17.2B — up 134% from $7.38B a quarter earlier.
Buyers outnumbered sellers: 160 funds opened new IMMU positions and 64 closed out — a net gain of 96 holders — while 87 added to existing stakes and 134 trimmed.
The largest buyer was HBK Investments, opening a new position worth an estimated $329M. The largest seller was Fidelity Investments, cutting an estimated $486M.
- 408 institutional investors held Immunomedics Inc (IMMU) as of Q3 2020, up from 313 in Q2 2020.
- Funds reported $17.2B of Immunomedics Inc stock for Q3 2020, up 134% quarter-over-quarter.
- 160 funds opened new Immunomedics Inc positions in Q3 2020 and 64 closed out, a net change of +96 holders.
- The largest Immunomedics Inc buyer in Q3 2020 was HBK Investments, an estimated $329M added.
- The largest Immunomedics Inc seller in Q3 2020 was Fidelity Investments, an estimated $486M sold.
Based on aggregated 13F filings for Q3 2020.